Whereas the status of the liver as privileged and exempt from humoral rejection has fallen, attempts at breaching the blood group barrier during transplantation have continued. Previously restricted to paediatric patients and emergencies, advances in immunosuppression protocols have improved outcomes to the point that ABO-incompatible liver transplantation might be more widely used in adults.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Song, G. W. et al. ABO-incompatible adult living donor liver transplantation under the desensitization protocol with rituximab. Am. J. Transplant. http://dx.doi.org/10.1111/ajt.13444.
Starzl, T. E. et al. Fifteen years of clinical liver transplantation. Gastroenterology 77, 375–388 (1979).
Gordon, R. D. et al. Liver transplantation across ABO blood groups. Surgery 100, 342–348 (1986).
Gugenheim, J., Samuel, D., Reynes, M. & Bismuth, H. Liver transplantation across ABO blood group barriers. Lancet 336, 519–523 (1990).
Tokunaga, Y. et al. Living related liver transplantation across ABO blood groups with FK506 and OKT3. Transpl. Int. 6, 313–318 (1993).
Nakamura, Y. et al. Successful case of adult ABO-incompatible liver transplantation: beneficial effects of intrahepatic artery infusion therapy: a case report. Transplant. Proc. 36, 2269–2273 (2004).
Tanabe, M. et al. Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation 73, 1959–1961 (2002).
Monteiro, I., McLoughlin, L. M., Fisher, A., de la Torre, A. N. & Koneru, B. Rituximab with plasmapheresis and splenectomy in abo-incompatible liver transplantation. Transplantation 76, 1648–1649 (2003).
Kawagishi, N. et al. New strategy for ABO-incompatible living donor liver transplantation with anti-CD20 antibody (rituximab) and plasma exchange. Transplant. Proc. 37, 1205–1206 (2005).
Egawa, H. et al. Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study. Am. J. Transplant. 14, 102–114 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Zarrinpar, A., Busuttil, R. Evading antigens—ABO-incompatible liver transplantation. Nat Rev Gastroenterol Hepatol 12, 676–678 (2015). https://doi.org/10.1038/nrgastro.2015.193
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2015.193